Figure 3.
Reduced efficacy of prophylactic FIXWT treatment in CRM+ compared with CRM− mice. SVBA evaluation of hemostasis 7 days after the infusion of 150 IU/kg of FIXWT in CRM− and CRM+ mice. Baseline SVBA in untreated CRM− (black) and CRM+ (orange) mice, CRM+ mice infused with FIXWT (green), CRM− mice infused with FIXWT (light green), and wild-type mice (red). Box plot rendition of the results showing the minimum, first quartile, median (waist), third quartile, and maximum values.